Nordmark Biotech

Nordmark Biotech is a privately held, revenue-generating German company with a century of expertise in biologics manufacturing. It operates as a full-service CDMO (Contract Development and Manufacturing Organization) with a strong focus on complex biological active ingredients like enzymes, positioning itself as a global leader in pancreatin and collagenase production. The company leverages its integrated 'Made in Germany' platform, FDA-approved cGMP facilities, and deep technical know-how to serve pharmaceutical clients from development through to commercial supply. Its established commercial products and contract services provide a stable revenue base while it invests in next-generation biotechnological capabilities.

Integrated platform for the extraction, purification, formulation, and analytical testing of complex biological active ingredients (particularly enzymes). Offers full-service CDMO capabilities from development to commercial cGMP manufacturing.

Operates in a niche competing with other specialized enzyme manufacturers (e.g., Vitrolife, Roche for research enzymes) and broader, large-scale CDMOs (e.g., Lonza, Catalent) for biopharmaceutical manufacturing contracts. Its differentiation lies in deep, specific expertise in enzyme biologics and a fully integrated, single-site service model.